Chengdu Shibeikang Biomedical Technology

Chengdu Shibeikang Biomedical Technology is a biotechnology company focused on the research and development of mRNA vaccines and therapeutic drugs. The company utilizes a proprietary mRNA synthesis and lipid nanoparticle (LNP) delivery platform to create a diverse pipeline targeting infectious diseases and oncology. Located in the Chengdu Tianfu International Bio-Town, Shibeikang aims to address global health challenges through innovative nucleic acid medicine. Their current efforts are centered on advancing mRNA candidates for respiratory viruses and cancer immunotherapy into clinical trials. The company is part of a strategic push in China to develop domestic mRNA manufacturing and delivery capabilities to reduce reliance on imported technologies.